I C: just the opposite on Mondays close,but a dead cat bounce is possible.
"I dislike the home infusion biz and I think in-store clinics are ridiculous". Like I said there is a steep learning curve in both of these business. However some these business exec. evolved into PBM's. Evolution and Darwin's theory. The next generation will emerge with more risk/reward going forward. Going back to RAD, The new CEO is all about volume and low margins, a good play if you are selling lemons or lettuce. I think RAD CEO needs to be tested and so far No big money interest. He may be Linked-in to the investor community but the Medical community is a social structure and that is where his short falling may be in play.
The Analysts seem to be coming in with more direction to where this market sector is heading. I have seen more negative than positive outlooks on earning going into next year. However increases in Prescription sales continue to rise, going forward with that outlook there has to be a bottoming out of price declines and a place for Convenient Community Drug stores in this sector. Long term buys vs Short term buys I will look into that..